Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Prostate Specific Antigen ELISA Kit

This Colorimetric ELISA kit is designed for the quantitative measurement of Human Prostate Specific Antigen.
Catalog No. ABIN5526768
$559.10
Plus shipping costs $50.00
96 tests
Shipping to: United States
Delivery in 3 to 5 Business Days

Quick Overview for Prostate Specific Antigen ELISA Kit (ABIN5526768)

Target

See all Prostate Specific Antigen (PSA) ELISA Kits
Prostate Specific Antigen (PSA)

Reactivity

  • 28
  • 12
  • 10
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Human

Detection Method

Colorimetric

Method Type

Sandwich ELISA

Detection Range

0.04 ng/mL - 40 ng/mL

Application

ELISA

Sample Type

Plasma, Cell Culture Supernatant, Serum
  • Minimum Detection Limit

    0.04 ng/mL

    Purpose

    This assay employs the quantitative sandwich enzyme immunoassay technique for the quantitative detection of human PSA.

    Analytical Method

    Quantitative

    Specificity

    PSA

    Components

    • Plate
    • Standard
    • Diluent

    Material not included

    Microplate reader capable of measuring absorbance at 450 nm, with correction wavelength set at 570 nm or 630 nm.
    Pipettes and pipette tips.
    50 μL to 300 μL adjustable multichannel micropipette with disposable tips.
    Multichannel micropipette reservoir.
    Beakers, flasks, cylinders necessary for preparation of reagents.
    Deionized or distilled water.
    Polypropylene test tubes for dilution.
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Sample Volume

    100 μL

    Assay Time

    3 - 4 h

    Plate

    Pre-coated

    Restrictions

    For Research Use only
  • Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Handling Advice

    protect your eyes

    Storage

    4 °C

    Storage Comment

    Store kit reagents between 2 and 8 °C. Immediately after use remaining reagents should be returned to cold storage (2 to 8 °C).
    Expiry of the kit and reagents is stated on labels. Expiration date of the kit components can only be guaranteed if the components are stored properly, and if, in case of repeated use of one component, this reagent is not contaminated by the first handling.
    Unopened Kit: Store at 2 - 8 °C (See expiration date on the label).
    Opened/Reconstituted Reagents: Up to 1 month at 2 - 8 °C.
    Reconstituted Standard: Up to 1 month at ≤ -20 °C in a manual defrost freezer. Avoid repeated freeze-thaw cycles.
    Microplate Wells: Up to 1 month at 2 - 8 °C. Return unused strips to the foil pouch containing the desiccant pack, reseal along entire edge to maintain plate integrity. Provided this is within the expiration date of the kit
  • Target See all Prostate Specific Antigen (PSA) ELISA Kits

    Prostate Specific Antigen (PSA)

    Alternative Name

    KLK3

    Background

    Prostate-specific antigen (PSA), also known as gamma-seminoprotein or kallikrein-3 (KLK3), is a glycoprotein enzyme encoded in humans by the KLK3 gene. PSA is a member of the kallikrein-related peptidase family and is secreted by the epithelial cells of the prostate gland. PSA is produced for the ejaculate, where it liquefies semen in the seminal coagulum and allows sperm to swim freely. It is also believed to be instrumental in dissolving cervical mucus, allowing the entry of sperm into the uterus. PSA is present in small quantities in the serum of men with healthy prostates, but is often elevated in the presence of prostate cancer or other prostate disorders. Obesity has been reported to reduce serum PSA levels. PSA levels can be also increased by prostatitis, irritation and benign prostatic hyperplasia producing a false positive result. PSA is not a unique indicator of prostate cancer, but may also detect prostatitis or benign prostatic hyperplasia. 30 percent of patients with high PSA have prostate cancer diagnosed after biopsy. Clinical practice guidelines for prostate cancer screening vary and are controversial due to uncertainty as to whether the benefits of screening ultimately outweigh the risks of overdiagnosis and over treatment.

    Gene ID

    354

    NCBI Accession

    NM_001030047

    UniProt

    P07288

    Pathways

    Complement System
You are here:
Chat with us!